Complexity-based dynamical assay for assessing the toxicity...

Surgery – Diagnostic testing – Cardiovascular

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C600S515000

Reexamination Certificate

active

07601124

ABSTRACT:
In a subject undergoing therapeutic intervention, efficacy of the therapeutic intervention is assessed based on a series of physiologic data associated with the subject. The series of physiologic data is analyzed to produce a measure of complexity. The complexity measure is then compared to a control. The efficacy of the therapeutic intervention is assessed based on the comparison of the complexity measure to the control. The control may be, for example, a complexity measure taken prior to initiation of the therapeutic intervention, a complexity measure taken from a different subject, or a predetermined threshold value. The measure of complexity is generated using, for example, a multiscale entropy measurement (MSE), a time asymmetry measurement, and/or an information-based similarity measurement. An increase in complexity indicates a positive effect of the therapeutic intervention, while a decrease in complexity indicates a negative effect of the therapeutic intervention.

REFERENCES:
patent: 5277189 (1994-01-01), Jacobs
patent: 6490478 (2002-12-01), Zhang et al.
patent: 6631291 (2003-10-01), Viertio-Oja et al.
patent: 2003/0163057 (2003-08-01), Flick et al.
Costa et al. “Multiscale Entropy to Distinguish Physioligic and Synthetic RR Time Series” Computers in Cardiology. 2002; 29:137-140.
Costa, et al., “Broken Asymmetry of the Human Heartbeat: Loss of Time Irreversibility in Aging and Disease,” PRL 95, 198102 (Nov. 2004).
Costa, et al., “Multiscale Entropy Analysis of Complex Physiologic Time Series,” PRL, vol. 89, No. 6, 068102 (Aug. 2002).
Costa, et al., “Multiscale Entropy Analysis of Complex Heart Rate Dynamics: Discrimination of Age and Heart Failure Effects,” Computers in Cardiology 30:705-708 (2003).
Costa, et al., “Noise and Poise: Enhancement of postural complexity in the elderly with a stochastic-resonance-based therapy,” EPL, 77, 68008 (Mar. 2007).
Yang, et al., “Information categorization approach to literary authorship disputes,” Physica A 329, 473-483 (Apr. 2003).
Costa, et al., “Multiscale entropy analysis of human gait dynamics,” Physica A 330, 53-60 (2003).
Yang, et al., “Linguistic Analysis of the Human Heartbeat Using Frequency and Rank Order Statistics,” PRL vol. 90, No. 10, 108103 (Mar. 2003).
“Costa, Goldberger, and Peng Reply:” PRL vol. 91, No. 11 (Sep. 2003).
“Costa, Goldberger, and Peng Reply:” PRL vol. 92, No. 8 (Feb. 2004).
“Yang et al. Reply:” PRL vol. 92, No. 10 (Mar. 2004).
Costa, et al., “Multiscale entropy analysis of biological signals,” PRL 71, 021906 (2005).
Suder, et al., “One-dimensional, nonlinear determinism characterizes heart rate pattern during paced respiration,” Am. J. Physiol. Hear Circ. Physiol. 275:1092-1102 (1998).
Hoekstra, et al., “Non-linear time series analysis: methods and applications to atrial fibrillation,” Ann. Ist. Super. Sanita, vol. 37, n.3, pp. 325-333 (2001).
Yang, et al., “Information-Based Similarity Index,” [online, Oct. 27, 2004] retrieved from the internet: URL: http://physionet.org/physiotools/ibs/doc/.
International Search Report for PCT/US06/05581, mailed Sep. 5, 2007.
Written Opinion of the International Searching Authority for PCT/US06/05581, mailed Sep. 5, 2007.
Goldberger et al., “What is physiologic complexity and how does it change with aging and disease?” Neurobiology of Aging 23, 23-26 (2002).
Bergman, U.M., “Stationarity and nonstationarity in single-equation regression analysis,” Department of Economics, Lund University (2003).
Costa, et al., “Multiscale Entropy to Distinguish Physiologic and Synthetic RR Time Series,” Computers and Cardiology 29:137-140 (2002).
Costa et al., “Multiscale Entropy Analysis (MSE),” [online, retrieved on Feb. 2, 2005], retrieved from the internet: URL: http://www.physionet.org/physiotools/mse/.
“Rational drug design,” [online, retrieved on Dec. 23, 2004], retrieved from internet: URL: http://www.wellcome.ac.uk/en/genome/tacklingdisease/hg09b002.html.
Marton MJ, et al. “Drug target validation and identification of secondary drug target effects using DNA microarrays,” Nat Med. Nov. 4, 1998,(11):1235-6 (Abstract provided).
Henry, C.M., “Structure-based Drug Design,” Science & Technology Pharmaceuticals, vol. 79, No. 23, pp. 69-74, Jun. 4, 2001.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Complexity-based dynamical assay for assessing the toxicity... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Complexity-based dynamical assay for assessing the toxicity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complexity-based dynamical assay for assessing the toxicity... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4054911

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.